Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study
- 1 June 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9171) , 2190-2194
- https://doi.org/10.1016/s0140-6736(98)05418-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Lamotrigine‐induced toxic epidermal necrolysis treated with intravenous cyclosporin: A discussion of pathogenesis and immunosuppressive managementAustralasian Journal of Dermatology, 1996
- Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysisBritish Journal of Dermatology, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methodsJournal of Clinical Epidemiology, 1995
- Is phenytoin contraindicated in patients receiving cranial irradiation ?Australasian Radiology, 1995
- Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting systemActa Neurologica Scandinavica, 1990
- Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1989
- Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty casesJournal of the American Academy of Dermatology, 1985
- STEVENS-JOHNSON SYNDROME IN PATIENTS RECEIVING RADIATION THERAPYThe Lancet, 1985
- Severe erythema multiforme (Stevens-Johnson syndrome) following telecobalt therapyThe British Journal of Radiology, 1972